IMNM
Price
$8.77
Change
+$0.09 (+1.04%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
764.84M
47 days until earnings call
RLAY
Price
$3.31
Change
+$0.05 (+1.53%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
569.2M
46 days until earnings call
Interact to see
Advertisement

IMNM vs RLAY

Header iconIMNM vs RLAY Comparison
Open Charts IMNM vs RLAYBanner chart's image
Immunome
Price$8.77
Change+$0.09 (+1.04%)
Volume$25.8K
Capitalization764.84M
Relay Therapeutics
Price$3.31
Change+$0.05 (+1.53%)
Volume$66.97K
Capitalization569.2M
IMNM vs RLAY Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. RLAY commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Buy and RLAY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (IMNM: $8.79 vs. RLAY: $3.32)
Brand notoriety: IMNM and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 71% vs. RLAY: 62%
Market capitalization -- IMNM: $764.84M vs. RLAY: $569.2M
IMNM [@Biotechnology] is valued at $764.84M. RLAY’s [@Biotechnology] market capitalization is $569.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 3 TA indicator(s) are bullish while RLAY’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 3 bullish, 4 bearish.
  • RLAY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than IMNM.

Price Growth

IMNM (@Biotechnology) experienced а -0.45% price change this week, while RLAY (@Biotechnology) price change was -1.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

IMNM is expected to report earnings on Aug 13, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($765M) has a higher market cap than RLAY($569M). IMNM YTD gains are higher at: -17.232 vs. RLAY (-19.417). IMNM has higher annual earnings (EBITDA): -175.18M vs. RLAY (-373.07M). RLAY has more cash in the bank: 710M vs. IMNM (317M). IMNM has less debt than RLAY: IMNM (4.77M) vs RLAY (47.2M). IMNM has higher revenues than RLAY: IMNM (10.9M) vs RLAY (7.68M).
IMNMRLAYIMNM / RLAY
Capitalization765M569M134%
EBITDA-175.18M-373.07M47%
Gain YTD-17.232-19.41789%
P/E RatioN/AN/A-
Revenue10.9M7.68M142%
Total Cash317M710M45%
Total Debt4.77M47.2M10%
TECHNICAL ANALYSIS
Technical Analysis
IMNMRLAY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVHIX5.900.02
+0.34%
Macquarie High Income Fund Class I
PRITX22.00N/A
N/A
T. Rowe Price International Stock
PJRQX9.06N/A
N/A
PGIM Quant Solutions International Eq R6
SIIIX16.23N/A
N/A
AlphaCentric Real Income I
FRBCX25.92N/A
N/A
JHancock Regional Bank C

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+1.27%
IDYA - IMNM
61%
Loosely correlated
+1.27%
RXRX - IMNM
55%
Loosely correlated
+4.65%
BEAM - IMNM
55%
Loosely correlated
+2.27%
SYRE - IMNM
54%
Loosely correlated
+3.96%
ARWR - IMNM
54%
Loosely correlated
+2.62%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+1.84%
XNCR - RLAY
52%
Loosely correlated
-1.87%
BCYC - RLAY
50%
Loosely correlated
+2.54%
IMNM - RLAY
49%
Loosely correlated
+1.27%
BDTX - RLAY
47%
Loosely correlated
-5.02%
RXRX - RLAY
46%
Loosely correlated
+4.65%
More